期刊文献+

小剂量多巴胺联合呋塞米治疗心力衰竭的临床疗效 被引量:4

Clinical effect of small doses of dopamine combined with furosemide in the treatment of heart failure
下载PDF
导出
摘要 目的探讨小剂量多巴胺联合呋塞米治疗心力衰竭的临床疗效。方法选取四川友谊医院2015年2月—2016年10月收治的心力衰竭患者90例,根据治疗方案不同将患者分为对照组与治疗组,各45例。对照组患者予以呋塞米治疗,治疗组患者在对照组治疗基础上予以小剂量多巴胺治疗,两组患者均连续治疗2周。比较两组患者临床疗效、心功能指标[心率(HR)、收缩压(SBP)、舒张压(DBP)、左心室射血分数(LVEF)、B型尿钠肽(BNP)]及不良反应发生情况。结果治疗组患者临床疗效优于对照组(P<0.05)。治疗组患者HR、SBP、DBP、BNP水平低于对照组,LVEF高于对照组(P<0.05)。两组患者均未发生严重不良反应。结论小剂量多巴胺联合呋塞米治疗心力衰竭的临床疗效确切,可有效改善患者心功能,缓解水钠潴留等症状。 Objective To investigate the clinical effect of small doses of dopamine combined with furosemide in the treatment of heart failure. Methods A total of 90 cases of heart failure patients were selected from February 2015 to October2016 in Sichuan Friendship Hospital,which were divided into control group and treatment group according to different treatments,45 cases in each group. Control group was given furosemide,treatment group was treated with small doses of dopamine based on control group,both groups were treated for 2 weeks. The clinical effect,cardiac function indexes( HR,SBP,DBP,LVEF,BNP) and the incidence of adverse reactions were compared between the two groups. Results The clinical effect of treatment group was better than control group( P〈0. 05). The treatment group of HR,SBP,DBP,BNP levels were lower than control group,LVEF was higher than control group( P〈0. 05). There were no serious adverse reactions happened. Conclusion Small doses of dopamine combined with furosemide have an exactly clinical effect in the treatment of heart failure,it can effectively improve the cardiac function,and alleviate symptoms such as retention of water and sodium.
作者 陆千军
出处 《临床合理用药杂志》 2017年第21期8-9,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 心力衰竭 呋塞米 多巴胺 治疗结果 Heart failure Furosemide Dopamine Treatment outcome
  • 相关文献

二级参考文献52

  • 1朱贤斌.多巴胺联合酚妥拉明治疗小儿肺炎合并心力衰竭疗效观察[J].临床医学,2006,26(11):39-40. 被引量:12
  • 2Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society o Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29: 2388- 2442.
  • 3Troosters T, Gnsselink R, Decmmer M. Six minute walking distance in healthy elderly subjects[ J]. Eur Respir J, 1999 ; 14:270 - 274.
  • 4Maisol A. B -type natriuretic peptide levels:diagnostic and prognos- tic in congestive heart failure : what" s next [ J ]. Circulation, 2002 ; 105:2328 - 2331.
  • 5张月宁.佑安住院医师手册[M].北京:中国协和医科大学出版社,2012: 58-60.
  • 6跃进,华伟.阜外心血管内科手册[M].北京:人民卫生出版社,2006:212-225.
  • 7医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007, 35(6): 1076-1095.
  • 8Mokhles MM, Trifiro G., Dieleman JP, et al. The risk of new onsetheart failure associated with dopamine agonist use in Parkinson'sdisease [J]. Pharmacological research, 2012,65(3): 358-364.
  • 9Rokutan H, Suckow C, VonHaehling S, et al. Furosemide inducesmortality in a rat model of chronic heart failure [J]. InternationalJournal of Cardiology, 2012,160(1): 20-25.
  • 10Tuttolomondo A, Pinto A, Parrinello G, et al. Intravenous high-dosefurosemide and hypertonic saline solutions for refractory heart fail-ure and ascites [J]. Seminars inNq)hrology, 2011, 31(6): 513-522.

共引文献104

同被引文献38

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部